CAPN9
Calpain-9
Also known as: CAN9_HUMAN, GC36, nCL-4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14815
- Gene
- CAPN9
- Ensembl
- ENSG00000135773
- Chromosome
- 1
- Canonical length
- 690 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Vesicles
OverviewNCBI Gene
Calpains are ubiquitous, well-conserved family of calcium-dependent, cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large subunit possesses a cysteine protease domain, and both subunits possess calcium-binding domains. Calpains have been implicated in neurodegenerative processes, as their activation can be triggered by calcium influx and oxidative stress. The protein encoded by this gene is expressed predominantly in stomach and small intestine and may have specialized functions in the digestive tract. This gene is thought to be associated with gastric cancer. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
690 residues, UniProt reviewed canonical sequence.
>O14815|CAPN9
1 MPYLYRAPGP QAHPVPKDAR ITHSSGQSFE QMRQECLQRG TLFEDADFPA SNSSLFYSER
61 PQIPFVWKRP GEIVKNPEFI LGGATRTDIC QGELGDCWLL AAIASLTLNQ KALARVIPQD
121 QSFGPGYAGI FHFQFWQHSE WLDVVIDDRL PTFRDRLVFL HSADHNEFWS ALLEKAYAKL
181 NGSYEALKGG SAIEAMEDFT GGVAETFQTK EAPENFYEIL EKALKRGSLL GCFIDTRSAA
241 ESEARTPFGL IKGHAYSVTG IDQVSFRGQR IELIRIRNPW GQVEWNGSWS DSSPEWRSVG
301 PAEQKRLCHT ALDDGEFWMA FKDFKAHFDK VEICNLTPDA LEEDAIHKWE VTVHQGSWVR
361 GSTAGGCRNF LDTFWTNPQI KLSLTEKDEG QEECSFLVAL MQKDRRKLKR FGANVLTIGY
421 AIYECPDKDE HLNKDFFRYH ASRARSKTFI NLREVSDRFK LPPGEYILIP STFEPHQEAD
481 FCLRIFSEKK AITRDMDGNV DIDLPEPPKP TPPDQETEEE QRFRALFEQV AGEDMEVTAE
541 ELEYVLNAVL QKKKDIKFKK LSLISCKNII SLMDTSGNGK LEFDEFKVFW DKLKQWINLF
601 LRFDADKSGT MSTYELRTAL KAAGFQLSSH LLQLIVLRYA DEELQLDFDD FLNCLVRLEN
661 ASRVFQALST KNKEFIHLNI NEFIHLTMNILocalizationUniProt · AlphaFold · HPA
Whether an antibody against CAPN9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 57 nTPM
Expression across tissuesHPA
Tissue
- stomach: 57 nTPM
- rectum: 21 nTPM
- colon: 13 nTPM
- small intestine: 11 nTPM
- salivary gland: 10 nTPM
- lung: 7.1 nTPM
Single-cell type
- goblet cells: 243 nCPM
- foveolar cells: 239 nCPM
- rod photoreceptor cells: 208 nCPM
- cone photoreceptor cells: 91 nCPM
- alveolar cells type 1: 54 nCPM
- mucous neck cells: 42 nCPM
Immune cell
- naive CD4 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- white matter: 7.9 nTPM
- basal ganglia: 5.8 nTPM
- medulla oblongata: 5.8 nTPM
- spinal cord: 5.2 nTPM
- pons: 4.8 nTPM
- midbrain: 4.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.1
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cysteine peptidase, cysteine active site
- Peptidase C2, calpain, catalytic domain
- EF-hand domain
- EF-hand domain pair
- EF-Hand 1, calcium-binding site
- Peptidase C2, calpain, large subunit, domain III
- Peptidase C2, calpain, domain III
- Peptidase C2, calpain family
- Calpain subdomain III
- Calpain large subunit, domain III superfamily
- Papain-like cysteine peptidase superfamily
- Calpain family cysteine protease
- Calpain large subunit, domain III
- EF-hand domain pair
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CAPN9 as an antibody target. Whether an autoantibody or antibody against CAPN9 could matter depends on whether native CAPN9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CAPN9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CAPN9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...